River Street Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.95M Buy
13,572
+1,977
+17% +$439K 1% 28
2025
Q4
$2.65M Sell
11,595
-154
-1% -$35.1K 0.99% 29
2025
Q3
$2.72M Buy
11,749
+476
+4% +$96.9K 1.05% 28
2025
Q2
$2.09M Sell
11,273
-59
-0.5% -$11K 0.9% 28
2025
Q1
$2.37M Buy
11,332
+513
+5% +$99.7K 1.18% 22
2024
Q4
$1.92M Buy
10,819
+224
+2% +$41.2K 0.98% 29
2024
Q3
$2.09M Buy
10,595
+1,179
+13% +$220K 1.14% 23
2024
Q2
$1.62M Buy
9,416
+1
+0% +$166 0.99% 29
2024
Q1
$1.71M Buy
9,415
+24
+0.3% +$4.14K 1.16% 25
2023
Q4
$1.46M Buy
9,391
+237
+3% +$34.6K 1.16% 22
2023
Q3
$1.36M Buy
9,154
+236
+3% +$34.6K 1.29% 20
2023
Q2
$1.2M Sell
8,918
-304
-3% -$44.6K 1.15% 22
2023
Q1
$1.47M Buy
9,222
+153
+2% +$23.4K 1.45% 14
2022
Q4
$1.47M Buy
+9,069
New +$1.39M 1.57% 12

Other funds holding ABBV